trans-4-Methylcyclohexanamine is an intermediate and can be used for the development of T. cruzi enzyme inhibitor[1].
[1]. Melissa F Adasme, et al. Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning. Int J Mol Sci. 2020 Nov 20;21(22):8809.
















